The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy-Reference-Cited by-同舟云学术

The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy

Published:1998-08 Issue:4 Volume:3 Page:237-252
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:The Oncologist

Author:

Ross Jeffrey S.¹,Fletcher Jonathan A.²

Affiliation:

1. Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York;

2. Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.3-4-237

Reference125 articles.

1. Amplification of c- erb B-2 and Aggressive Human Breast Tumors?

2. The neu-oncogene: More than a prognostic indicator?

3. Interaction between erbB- receptors and heregulin in breast cancer tumor progression and drug resistance

4. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

5. Correlation of c‐erb B2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading;Berger MS;Cancer Res,1988

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ErbB2/HER2 expression level determines CDK4-inhibitor sensitivity and cyclin D1 and c-Myc dependency at the G1/S transition;2024-05-14

2. HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity;Oncotarget;2024-01-06

3. Low-level expression of human Epidermal growth Factor Receptor-2 (HER2) in High-Grade Mullerian Tumors: Implications for therapy decision making;Gynecologic Oncology Reports;2023-10

4. Clinicopathological characteristics and prognosis of early-stage HER2 low-expression breast cancer: A single-center retrospective study;Frontiers in Oncology;2023-03-29

5. Clinicopathological characteristics and features of molecular subtypes of breast cancer at high altitudes;Frontiers in Oncology;2023-01-13